Clinical Trial Update: A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of ZSTK474 in Japanese patients with advanced solid malignancies has completed. The study was sponsored by Zenyaku Kogyo Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• ZSTK474 (ZSTK474)

Snippet

Sponsor: Zenyaku Kogyo Co., Ltd. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED